Xell AG - Company Review
SummaryXell AG - Company Review
Summary
Xell AG (Xell) is a provider of customized solutions in cell culture technology. It developed culture media, supplements and feeds for production cell lines including Chinese hamster ovary (CHO), hybridoma and human embryonic kidney (HEK). The company offers products which include TCX6D Medium, Basic CHO Feed, TCX7D Feed, TCX10D Medium, HEK GM, HEK TF, HEK FS, CHOMACS CD, HybriMACS CD among others. Xell also provides services such as cell studies, LOT testing, raw material and media supplier evaluation, feeding strategy, control loops, substrate and product analytics. The company works in collaboration with biotechnology companies and universities such as ACYTE Biotech Pty Ltd, BIBITEC GmbH, AIBN, University of Queensland, Bielefeld University and others. Xell is headquartered in Bielefeld, Germany.
This comprehensive company report of Xell AG provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.